Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
American Journal of Infection Control|October 24, 2024
Infection prevention and control in long-term care facilities in Florida: A needs assessment surveyCindy Prins, Avery E Bollinger, Cassandra L Johnson, et al.
Open Forum Infectious Diseases|April 22, 2026
Multicenter Evaluation of Ceftazidime/Avibactam in Pediatric Patients Across the United States: Real-World Insights into the Management of Drug-Resistant Gram-Negative InfectionsTaylor Morrisette, Grant T Stimes, Gustavo R Alvira-Arill, et al.
Open Forum Infectious Diseases|August 25, 2021
Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant <i>Enterobacterales</i> and <i>Pseudomonas aeruginosa</i>Sara Alosaimy, Abdalhamid M Lagnf, Taylor Morrisette, et al.
Open Forum Infectious Diseases|April 11, 2025
Real-World Applications of Imipenem-Cilastatin-Relebactam: Insights From a Multicenter Observational Cohort StudyKaylee E Caniff, Nicholas Rebold, Xhilda Xhemali, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2022
Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-TazobactamSara Alosaimy, Abdalhamid M Lagnf, Athena L V Hobbs, et al.
Antimicrobial Agents and Chemotherapy|May 15, 2026
Ceftazidime-avibactam for multidrug-resistant gram-negative infections: outcomes and timing of initiation across 22 U.S. medical centersAshlan J Kunz Coyne, Chloe Judd, Kristen Lucas, et al.
The Lancet. Infectious Diseases|December 19, 2024
Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational studyRyan K Shields, Lilian M Abbo, Renee Ackley, et al.
Pageof 5